跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IL-2 variant mutant
首页
药物
IL-2 variant mutant
IL-2 variant mutant
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
AN IL-2 VARIANT FUSION PROTEIN AND ITS APPLICATIONS
WO 2026149179 A1
申请人: BAICHENGHAO BIOPHARMACEUTICAL CHENGDU CO LTD
优先权: 2025
CN
WO
2 件公开
Human interleukin-2 variant or derivative thereof
CN 111647068 A
申请人: JIANGSU HENGRUI MEDICINE CO
优先权: 2019
CN
Tumor vaccine based on mRNA (messenger ribonucleic acid) as well as preparation and combined
CN 114588255 A
申请人: SUZHOU XINLONG BIOMEDICAL SCIENCE AND TECH LIMITED COMPANY
优先权: 2022
CN
IL-2 SUPERANTAGONIST CONSTRUCTS, METHODS AND USES THEREOF
CN 119998312 A
申请人: MEDICENNA THERAPEUTICS PTE LTD
优先权: 2022
CN
IL-2 variant, PD-1 antibody and VEGF receptor fusion protein and application thereof
CN 121949568 A
申请人: HEFEI TIANGANG IMMUNOLOGY PHARMACEUTICAL CO LTD
优先权: 2025
CN
药物
反馈